Nanomedicine-mediated therapies to target breast cancer stem cells
Accumulating evidences have suggested the existence of breast cancer stem cells (BCSCs), which possess the potential of both self-renewal and differentiation. The origin of BCSCs might have relationship to the development of normal mammary stem cells. BCSCs are believed to play a key role in the ini...
Saved in:
Main Authors: | Lili He (Author), Jian Gu (Author), Lee Yong Lim (Author), Zhi-xiang Yuan (Author), Jingxin Mo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells
by: Zhi-xiang Yuan, et al.
Published: (2016) -
Functional Nanomedicines for Targeted Therapy of Bladder Cancer
by: Chao Tang, et al.
Published: (2021) -
Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges
by: Md. Rizwanullah, et al.
Published: (2021) -
Cancer Stem Cells and Nanomedicine
by: Entela Shkembi, et al.
Published: (2016) -
Nanomedicine strategies to counteract cancer stemness and chemoresistance
by: Huayu Liu, et al.
Published: (2023)